Stable activatable particles as radiotherapeutic agents for the treatment of disease
US9327038B2 · kind B2 · utility
1Cited by
2References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 2012 |
| Grant date | May 3, 2016 |
| Priority date | — |
| Expiry date | Apr 28, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K51/1227
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides radiotherapeutic agents and compositions and methods for making and using the same. In some embodiments, the radiotherapeutic agent is a nanoparticle comprising a radionuclide and a carrier moiety. In some embodiments, the radionuclide is produced by activating a stable activatable particle via neutron activation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.